Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha

The crude extract of Carthamus oxycantha (Co.Cr) and its fractions were studied in vitro for their possible spasmogenic and spasmolytic activities. Co.Cr (0.03–10 mg/mL) caused an atropine sensitive spasmogenic effect in guinea‐pig ileum. In spontaneously contracting rabbit jejunum preparations, Co....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Phytotherapy research 2005-08, Vol.19 (8), p.679-683
Hauptverfasser: Gilani, A.H, Bukhari, I.A, Khan, R.A, Khan, A.U, Ullah, F, Ahmad, V.U
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 683
container_issue 8
container_start_page 679
container_title Phytotherapy research
container_volume 19
creator Gilani, A.H
Bukhari, I.A
Khan, R.A
Khan, A.U
Ullah, F
Ahmad, V.U
description The crude extract of Carthamus oxycantha (Co.Cr) and its fractions were studied in vitro for their possible spasmogenic and spasmolytic activities. Co.Cr (0.03–10 mg/mL) caused an atropine sensitive spasmogenic effect in guinea‐pig ileum. In spontaneously contracting rabbit jejunum preparations, Co.Cr caused a dose‐dependent (0.03–3.0 mg/mL) spasmogenic effect, followed by relaxation at the next higher doses of 5.0–10.0 mg/mL. In the presence of atropine, the spasmogenic effect was blocked and the relaxant effect was observed at lower doses (0.1–5.0 mg/mL), shifting the inhibitory dose‐response curves to the left. Co.Cr also inhibited K+ (80 mm)‐induced contractions in atropinized preparations at similar doses, suggesting calcium channel blockade (CCB) activity. The CCB effect was further confirmed when pretreatment of the tissue with Co.Cr produced a dose‐dependent shift in the Ca++ dose‐response curves to the right, similar to that caused by verapamil. Activity‐directed fractionation revealed that the spasmolytic effect was concentrated in organic fractions in the following order of potency: hexane > ethylacetate > chloroform, while the aqueous fraction exhibited spasmogenic and weak spasmolytic effects. These results indicate that Carthamus oxycantha contains a combination of spasmogenic (cholinergic) and spasmolytic (calcium antagonist) constituents. Copyright © 2005 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/ptr.1727
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68628748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17372813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5087-5fc2152e394b586f5fc171c769e046de8c759df8c1d9479ed31103e73d05b03c3</originalsourceid><addsrcrecordid>eNqF0k1P3DAQBmCragVbisQvgFyoegmdsePYPqKoSyvRD1FQe7O8jsMa8rHYScv--xptVE5VT9ZIj2c8r0zIEcIZAtD3mzGcoaDiBVkgKJUjF-wlWYDimBcof-6T1zHeAYCiUOyRfSxRCCVgQT5X66H1_dD5zo3eZqavM2ta66cus2vT967NVu1g731_mxk7-l9-9C5mQ5NVJoxr002peNxa06fiDXnVmDa6w_k8IDfLD9fVx_zy68Wn6vwytxykyHljKXLqmCpWXJZNqlGgFaVyUJS1k1ZwVTfSYq0KoVzNEIE5wWrgK2CWHZC3u76bMDxMLo6689G6tjW9G6aoS1lSKQr5X4iCCSqRJfhuB20YYgyu0ZvgOxO2GkE_ZaxTxvop40SP557TqnP1M5xDTeB0BiamLJtgeuvjsxNIJaMquXznfvvWbf85UH-7vpoHz97H0T3-9Sbc6zLtwfWPLxfpRimXFVvqq-RPdr4xgza3Ib3h5jsFZJDSLHj6I38AqtyqNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17372813</pqid></control><display><type>article</type><title>Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Gilani, A.H ; Bukhari, I.A ; Khan, R.A ; Khan, A.U ; Ullah, F ; Ahmad, V.U</creator><creatorcontrib>Gilani, A.H ; Bukhari, I.A ; Khan, R.A ; Khan, A.U ; Ullah, F ; Ahmad, V.U</creatorcontrib><description>The crude extract of Carthamus oxycantha (Co.Cr) and its fractions were studied in vitro for their possible spasmogenic and spasmolytic activities. Co.Cr (0.03–10 mg/mL) caused an atropine sensitive spasmogenic effect in guinea‐pig ileum. In spontaneously contracting rabbit jejunum preparations, Co.Cr caused a dose‐dependent (0.03–3.0 mg/mL) spasmogenic effect, followed by relaxation at the next higher doses of 5.0–10.0 mg/mL. In the presence of atropine, the spasmogenic effect was blocked and the relaxant effect was observed at lower doses (0.1–5.0 mg/mL), shifting the inhibitory dose‐response curves to the left. Co.Cr also inhibited K+ (80 mm)‐induced contractions in atropinized preparations at similar doses, suggesting calcium channel blockade (CCB) activity. The CCB effect was further confirmed when pretreatment of the tissue with Co.Cr produced a dose‐dependent shift in the Ca++ dose‐response curves to the right, similar to that caused by verapamil. Activity‐directed fractionation revealed that the spasmolytic effect was concentrated in organic fractions in the following order of potency: hexane &gt; ethylacetate &gt; chloroform, while the aqueous fraction exhibited spasmogenic and weak spasmolytic effects. These results indicate that Carthamus oxycantha contains a combination of spasmogenic (cholinergic) and spasmolytic (calcium antagonist) constituents. Copyright © 2005 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0951-418X</identifier><identifier>EISSN: 1099-1573</identifier><identifier>DOI: 10.1002/ptr.1727</identifier><identifier>PMID: 16177970</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Animals ; Biological and medical sciences ; Biomimetics ; calcium antagonist ; Calcium Channel Blockers - pharmacology ; Calcium Signaling ; Carthamus - chemistry ; Carthamus oxycantha ; cholinergic ; Dose-Response Relationship, Drug ; Female ; General pharmacology ; Guinea Pigs ; Ileum - drug effects ; Jejunum - drug effects ; Male ; Medical sciences ; Muscle Contraction - drug effects ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments ; Plant Extracts - chemistry ; Plant Extracts - pharmacology ; Rabbits ; spasmogenic ; spasmolytic</subject><ispartof>Phytotherapy research, 2005-08, Vol.19 (8), p.679-683</ispartof><rights>Copyright © 2005 John Wiley &amp; Sons, Ltd.</rights><rights>2005 INIST-CNRS</rights><rights>Copyright (c) 2005 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5087-5fc2152e394b586f5fc171c769e046de8c759df8c1d9479ed31103e73d05b03c3</citedby><cites>FETCH-LOGICAL-c5087-5fc2152e394b586f5fc171c769e046de8c759df8c1d9479ed31103e73d05b03c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fptr.1727$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fptr.1727$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17128329$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16177970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilani, A.H</creatorcontrib><creatorcontrib>Bukhari, I.A</creatorcontrib><creatorcontrib>Khan, R.A</creatorcontrib><creatorcontrib>Khan, A.U</creatorcontrib><creatorcontrib>Ullah, F</creatorcontrib><creatorcontrib>Ahmad, V.U</creatorcontrib><title>Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha</title><title>Phytotherapy research</title><addtitle>Phytother. Res</addtitle><description>The crude extract of Carthamus oxycantha (Co.Cr) and its fractions were studied in vitro for their possible spasmogenic and spasmolytic activities. Co.Cr (0.03–10 mg/mL) caused an atropine sensitive spasmogenic effect in guinea‐pig ileum. In spontaneously contracting rabbit jejunum preparations, Co.Cr caused a dose‐dependent (0.03–3.0 mg/mL) spasmogenic effect, followed by relaxation at the next higher doses of 5.0–10.0 mg/mL. In the presence of atropine, the spasmogenic effect was blocked and the relaxant effect was observed at lower doses (0.1–5.0 mg/mL), shifting the inhibitory dose‐response curves to the left. Co.Cr also inhibited K+ (80 mm)‐induced contractions in atropinized preparations at similar doses, suggesting calcium channel blockade (CCB) activity. The CCB effect was further confirmed when pretreatment of the tissue with Co.Cr produced a dose‐dependent shift in the Ca++ dose‐response curves to the right, similar to that caused by verapamil. Activity‐directed fractionation revealed that the spasmolytic effect was concentrated in organic fractions in the following order of potency: hexane &gt; ethylacetate &gt; chloroform, while the aqueous fraction exhibited spasmogenic and weak spasmolytic effects. These results indicate that Carthamus oxycantha contains a combination of spasmogenic (cholinergic) and spasmolytic (calcium antagonist) constituents. Copyright © 2005 John Wiley &amp; Sons, Ltd.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomimetics</subject><subject>calcium antagonist</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Calcium Signaling</subject><subject>Carthamus - chemistry</subject><subject>Carthamus oxycantha</subject><subject>cholinergic</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>General pharmacology</subject><subject>Guinea Pigs</subject><subject>Ileum - drug effects</subject><subject>Jejunum - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle Contraction - drug effects</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>Rabbits</subject><subject>spasmogenic</subject><subject>spasmolytic</subject><issn>0951-418X</issn><issn>1099-1573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0k1P3DAQBmCragVbisQvgFyoegmdsePYPqKoSyvRD1FQe7O8jsMa8rHYScv--xptVE5VT9ZIj2c8r0zIEcIZAtD3mzGcoaDiBVkgKJUjF-wlWYDimBcof-6T1zHeAYCiUOyRfSxRCCVgQT5X66H1_dD5zo3eZqavM2ta66cus2vT967NVu1g731_mxk7-l9-9C5mQ5NVJoxr002peNxa06fiDXnVmDa6w_k8IDfLD9fVx_zy68Wn6vwytxykyHljKXLqmCpWXJZNqlGgFaVyUJS1k1ZwVTfSYq0KoVzNEIE5wWrgK2CWHZC3u76bMDxMLo6689G6tjW9G6aoS1lSKQr5X4iCCSqRJfhuB20YYgyu0ZvgOxO2GkE_ZaxTxvop40SP557TqnP1M5xDTeB0BiamLJtgeuvjsxNIJaMquXznfvvWbf85UH-7vpoHz97H0T3-9Sbc6zLtwfWPLxfpRimXFVvqq-RPdr4xgza3Ib3h5jsFZJDSLHj6I38AqtyqNw</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Gilani, A.H</creator><creator>Bukhari, I.A</creator><creator>Khan, R.A</creator><creator>Khan, A.U</creator><creator>Ullah, F</creator><creator>Ahmad, V.U</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>FBQ</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>200508</creationdate><title>Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha</title><author>Gilani, A.H ; Bukhari, I.A ; Khan, R.A ; Khan, A.U ; Ullah, F ; Ahmad, V.U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5087-5fc2152e394b586f5fc171c769e046de8c759df8c1d9479ed31103e73d05b03c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomimetics</topic><topic>calcium antagonist</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Calcium Signaling</topic><topic>Carthamus - chemistry</topic><topic>Carthamus oxycantha</topic><topic>cholinergic</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>General pharmacology</topic><topic>Guinea Pigs</topic><topic>Ileum - drug effects</topic><topic>Jejunum - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle Contraction - drug effects</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>Rabbits</topic><topic>spasmogenic</topic><topic>spasmolytic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilani, A.H</creatorcontrib><creatorcontrib>Bukhari, I.A</creatorcontrib><creatorcontrib>Khan, R.A</creatorcontrib><creatorcontrib>Khan, A.U</creatorcontrib><creatorcontrib>Ullah, F</creatorcontrib><creatorcontrib>Ahmad, V.U</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Phytotherapy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilani, A.H</au><au>Bukhari, I.A</au><au>Khan, R.A</au><au>Khan, A.U</au><au>Ullah, F</au><au>Ahmad, V.U</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha</atitle><jtitle>Phytotherapy research</jtitle><addtitle>Phytother. Res</addtitle><date>2005-08</date><risdate>2005</risdate><volume>19</volume><issue>8</issue><spage>679</spage><epage>683</epage><pages>679-683</pages><issn>0951-418X</issn><eissn>1099-1573</eissn><abstract>The crude extract of Carthamus oxycantha (Co.Cr) and its fractions were studied in vitro for their possible spasmogenic and spasmolytic activities. Co.Cr (0.03–10 mg/mL) caused an atropine sensitive spasmogenic effect in guinea‐pig ileum. In spontaneously contracting rabbit jejunum preparations, Co.Cr caused a dose‐dependent (0.03–3.0 mg/mL) spasmogenic effect, followed by relaxation at the next higher doses of 5.0–10.0 mg/mL. In the presence of atropine, the spasmogenic effect was blocked and the relaxant effect was observed at lower doses (0.1–5.0 mg/mL), shifting the inhibitory dose‐response curves to the left. Co.Cr also inhibited K+ (80 mm)‐induced contractions in atropinized preparations at similar doses, suggesting calcium channel blockade (CCB) activity. The CCB effect was further confirmed when pretreatment of the tissue with Co.Cr produced a dose‐dependent shift in the Ca++ dose‐response curves to the right, similar to that caused by verapamil. Activity‐directed fractionation revealed that the spasmolytic effect was concentrated in organic fractions in the following order of potency: hexane &gt; ethylacetate &gt; chloroform, while the aqueous fraction exhibited spasmogenic and weak spasmolytic effects. These results indicate that Carthamus oxycantha contains a combination of spasmogenic (cholinergic) and spasmolytic (calcium antagonist) constituents. Copyright © 2005 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>16177970</pmid><doi>10.1002/ptr.1727</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0951-418X
ispartof Phytotherapy research, 2005-08, Vol.19 (8), p.679-683
issn 0951-418X
1099-1573
language eng
recordid cdi_proquest_miscellaneous_68628748
source MEDLINE; Wiley Online Library All Journals
subjects Animals
Biological and medical sciences
Biomimetics
calcium antagonist
Calcium Channel Blockers - pharmacology
Calcium Signaling
Carthamus - chemistry
Carthamus oxycantha
cholinergic
Dose-Response Relationship, Drug
Female
General pharmacology
Guinea Pigs
Ileum - drug effects
Jejunum - drug effects
Male
Medical sciences
Muscle Contraction - drug effects
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
Plant Extracts - chemistry
Plant Extracts - pharmacology
Rabbits
spasmogenic
spasmolytic
title Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A08%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cholinomimetic%20and%20calcium%20channel%20blocking%20activities%20of%20Carthamus%20oxycantha&rft.jtitle=Phytotherapy%20research&rft.au=Gilani,%20A.H&rft.date=2005-08&rft.volume=19&rft.issue=8&rft.spage=679&rft.epage=683&rft.pages=679-683&rft.issn=0951-418X&rft.eissn=1099-1573&rft_id=info:doi/10.1002/ptr.1727&rft_dat=%3Cproquest_cross%3E17372813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17372813&rft_id=info:pmid/16177970&rfr_iscdi=true